Global Bio-chem Technology Group Co. Ltd. (DE:GLY)
FRANKFURT:GLY
GLY Stock Chart & Stats
€0.01
€0.00(0.00%)
At close: 4:00 PM EST
€0.01
€0.00(0.00%)
Day’s Range― - ―
52-Week Range<€0.01 - €0.01
Previous CloseN/A
Volume0.00
Average Volume (3M)10.42K
Market Cap
€109.45M
Enterprise Value€2.23B
Total Cash (Recent Filing)€94.44M
Total Debt (Recent Filing)€1.79B
Price to Earnings (P/E)17.3
Beta-0.73
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding16,832,771,000
10 Day Avg. Volume31,250
30 Day Avg. Volume10,416
Financial Highlights & Ratios
PEG Ratio-0.13
Price to Book (P/B)-3.27
Price to Sales (P/S)0.74
P/FCF Ratio-59.64
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Diverse Corn-based PortfolioGlobal Bio-chem sells amino acids (notably lysine), food additives and other corn-derived products across animal nutrition, food and industrial end markets. This product and end-market diversification supports more stable long-term demand and reduces exposure to a single cyclical sector.
Integrated Manufacturing FootprintThe group's integrated manufacturing and sales operations provide control over processing, co-product capture and logistics. Vertical integration can protect margins versus pure traders, enable scale advantages, and support durability through production flexibility and raw-material processing expertise.
Proven Ability To Generate Positive Reported ProfitsAlthough EBIT has been weak, the company produced positive reported net income in several recent years and has demonstrated revenue growth spurts (notably 2023). That track record indicates the business can generate earnings and occasionally convert to positive cash under favorable conditions.
Bears Say
Negative Shareholders' EquityPersistent negative equity signals structural balance-sheet weakness: it elevates insolvency risk, constrains access to capital, and limits the firm’s ability to absorb shocks or invest. Over-leverage reduces strategic flexibility and increases refinancing and covenant risk over months to years.
Weak And Volatile Operating ProfitabilityThin gross margins and consecutive negative EBIT indicate the core manufacturing business struggles to consistently cover operating costs. Revenue volatility (sharp drop in 2025) compounds margin pressure, making sustainable profitability dependent on improved cost structure or pricing power.
Unstable Cash GenerationRepeated periods of negative operating and free cash flow show poor cash conversion and operational stress. Weak, inconsistent cash generation undermines the firm's ability to service large debt, fund capex or weather commodity input swings without external financing.
Global Bio-chem Technology Group Co. Ltd. News
GLY FAQ
What was Global Bio-chem Technology Group Co. Ltd.’s price range in the past 12 months?
Global Bio-chem Technology Group Co. Ltd. lowest stock price was <€0.01 and its highest was €0.01 in the past 12 months.
What is Global Bio-chem Technology Group Co. Ltd.’s market cap?
Global Bio-chem Technology Group Co. Ltd.’s market cap is €109.45M.
When is Global Bio-chem Technology Group Co. Ltd.’s upcoming earnings report date?
Global Bio-chem Technology Group Co. Ltd.’s upcoming earnings report date is Aug 27, 2026 which is in 77 days.
How were Global Bio-chem Technology Group Co. Ltd.’s earnings last quarter?
Global Bio-chem Technology Group Co. Ltd. released its earnings results on Mar 27, 2026. The company reported €0.003 earnings per share for the quarter, beating the consensus estimate of N/A by €0.003.
Is Global Bio-chem Technology Group Co. Ltd. overvalued?
According to Wall Street analysts Global Bio-chem Technology Group Co. Ltd.’s price is currently Overvalued.
Does Global Bio-chem Technology Group Co. Ltd. pay dividends?
Global Bio-chem Technology Group Co. Ltd. does not currently pay dividends.
What is Global Bio-chem Technology Group Co. Ltd.’s EPS estimate?
Global Bio-chem Technology Group Co. Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Global Bio-chem Technology Group Co. Ltd. have?
Global Bio-chem Technology Group Co. Ltd. has 16,832,771,000 shares outstanding.
What happened to Global Bio-chem Technology Group Co. Ltd.’s price movement after its last earnings report?
Global Bio-chem Technology Group Co. Ltd. reported an EPS of €0.003 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Global Bio-chem Technology Group Co. Ltd.?
Currently, no hedge funds are holding shares in DE:GLY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Global Bio-chem Technology Group Co. Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
20.00%
12-Months-Change
Fundamentals
Return on Equity
-11.47%
Trailing 12-Months
Asset Growth
1.69%
Trailing 12-Months
Company Description
Global Bio-chem Technology Group Co. Ltd.
Global Bio-chem Technology Group Company Limited, an investment holding enterprise, is engaged in the global production and distribution of both refined corn products and biochemicals derived from corn. Its market reach extends across the People's Republic of China, other Asian countries, the Americas, and international territories. The group's operations are divided into four main divisions: Upstream Products, Amino Acids, Corn Sweeteners, and Polyol Chemicals. The company's diverse product portfolio includes a range of corn-refined items such as corn oil, corn steep liquor, corn starch, waxy corn starch, corn gluten meal, feed pellets, and corn germ cake. Furthermore, it offers a variety of downstream corn-based biochemicals, encompassing amino acids like lysine, protein lysine, threonine, and glutamic acid. Its corn sweeteners segment includes high fructose corn syrup, maltodextrin, high maltose syrup, maltose syrup, sorbitol, glucose, and crystallized glucose. Additionally, the firm manufactures modified starches and various chemicals, such as ethylene, propylene, butylene glycols, and resins. Complementing these, the company also supplies anti-freeze solutions, hydrogen, and ammonia. These products serve a multitude of applications across numerous industries, including animal feed manufacturing, food and beverage production, cosmetics, textiles, pharmaceuticals, and the broader chemical sector. Established in 1994, the company's headquarters are situated in Hung Hom, Hong Kong.
Technical Analysis
Global Sweeteners Holdings Limited
―
Natural Food International Holding Ltd.
―
Vedan International (Holdings) Ltd.
―
China Starch Holdings Limited
―
Asia Cassava Resources Holdings Limited
―
Options Prices
Currently, No data available
---